Literature DB >> 30521583

The burden of stroke in China: Results from a nationwide population-based epidemiological survey.

Yilu Gao1,2, Bin Jiang1,2, Haixin Sun1,2, Xiaojuan Ru1,2, Dongling Sun1,2, Linhong Wang3, Limin Wang3, Yong Jiang4, Valery L Feigin5, Yilong Wang4, Wenzhi Wang1,2.   

Abstract

Stroke is a serious threat to human health that often leads to severe complications, and currently ranks first as leading cause of death in China. However, reliable data on stroke burden in China in the 21st century are lacking. We used the data from NESS-China (National Epidemiological Survey of Stroke in China) for assessing the adverse health effects of stroke in Chinese population. We carried out inter-regional comparative study in order to obtain regular burden related characteristics of stroke in China, as measured by YLLs (years of life lost due to premature mortality), YLDs (years lived with disability) and DALYs (disability adjusted life years). Amongst the nationwide population of 596,536 individuals of all ages in 2013, the YLLs for stroke was 1748, the YLDs was 262, and the DALYs was 2010(per 100,000). The gender subtype analysis of DALYs was 2171(male) and 1848(female). The YLLs, YLDs and DALYs in rural areas were higher compared to urban areas. Among the 18 age groups, the highest YLLs was observed in ≥ 80 years old group. The impact of stroke on Chinese population is more severe compared to the global average levels. Stroke results as the main cause of YLLs in China, while there is no significant difference for the YLDs. Nevertheless, DALYs caused by stroke rank 3th in global epidemiologic study territories, 1st in China.

Entities:  

Mesh:

Year:  2018        PMID: 30521583      PMCID: PMC6283556          DOI: 10.1371/journal.pone.0208398

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

Currently, stroke is the leading cause of death in China[1, 2], and its adverse consequences to the physical health are becoming ever more serious[3, 4]. Conducting epidemiological studies and clarifying the burdens associated with this disease are crucial for establishing prevention and control strategies, and for evidence-based allocation of public health resources[5-7]. However, reliable data on stroke burden in China in the 21st century are lacking. During “The Twelfth Five-year Plan” (2011–2015), National Ministry of Science and Technology and National Health Planning Commission instigated the program of “National Epidemiological Survey of Stroke in China (NESS-China)”, and carried out an epidemiological survey on cerebrovascular disease at 155 different survey sites in 31 provinces. The scope of this initiative was to acquire the basic information regarding the current level of burden from and trends of cerebrovascular diseases in China, the basic risk factors, as well as the prevention and treatment of stroke in Chinese people. This epidemiological survey involved the largest sample scale in the field of cerebrovascular diseases since the foundation of People’s Republic of China [8]. The present research utilized the data from this survey especially focusing on the burden of stroke in China. The current health impact caused by stroke in relation to stroke induced disability and premature deaths were considered. Furthermore, socio-economic factors, the inter-regional differences in development status, different levels of public medical facilities and different geographical and climatic conditions were also considered in order to acquire a full comprehension of the factors influencing the burden of stroke in China.

Methods

Sampling method

NESS-China includes data from 2010 census[9] that represent current characteristics of Chinese rural and urban residents. These results were obtained using multilevel cluster random sampling method at 157 survey sites in 31 provinces (autonomous regions, municipalities). The National Disease Surveillance systems[1, 10] of the National Center for Chronic and Non-communicable Disease Control and Prevention of Chinese Center for Disease Control and Prevention, sampled at least 4,500 people at each survey site, and included 3,800 surveys (response rate ≥80%). The total sample size of the study population was 600,000[8].

Ethical approval

The study was approved by the ethical review committees of Beijing Tiantan Hospital and all other participating institutes. Written informed consent was obtained from all study participants by interviewers before data collection. We can confirm that all methods were performed in accordance with the relevant guidelines and regulations.

Diagnostic criteria

The stroke diagnostic criteria proposed by “Atherosclerosis Risk In Communities Study (ARIC)” were applied, such as “abruptly and rapidly evolutional focal/whole cranial nerve function defection, with the symptoms lasting more than 24 hours (unless surgical intervention is conducted or death is caused), without obvious reasons other than vascular factors, excluding abnormal nerve function caused by trauma, metabolic disturbance, poisoning, tumour or infection of central nervous system”[11]. The stroke mortality was determined by reviewing medical history (verbal autopsy), relevant medical records and neuroimaging examination materials when available. Modified Rankin Scale (mRS)[12] was used to determine the sequela disability status in definite stroke cases[13].

Procedures

The verification and inclusion of stroke sufferers and stroke mortalities was done via two–staged survey.[8] The first stage of the survey was done by trained investigators from the Centre for Disease Control who adopted face-to-face investigation approach at survey sites, regarding the household as the unit. They elucidated the relevant information for "cerebrovascular disease symptom screening and simple check-up" in the "Preliminary Screening Table of Epidemiology Survey of Cerebrovascular Diseases" to identify patients with suspected stroke and a history of stroke. They also obtained "family members death information" in the "Preliminary Screening Table" and death related information from the Centre for Disease Control during time period from September 1, 2012 to August 31, 2013. These data were submitted to the study neurologists for reviewing. At least 3,800 residents of all age groups at each study site completed the primary screening survey. The second stage of the survey was carried out primarily by professional neurologists who conducted face-to-face interviews and clinical/neurological examination of the study participants suspected to have a stroke, including reviewing of related medical records and neuroimaging data (when available) to confirm or refute the diagnosis of stroke. The relevant content was recorded in the "Registration Form of Definite Cases of Cerebrovascular Diseases" and included information on the onset time of stroke, sequelae disability status, duration of disability, and other relevant information. With reference to deceased, "Review Registration Form of Death Cases" was completed to determine the cause of deaths.

Quality control

A close coordination and cooperation between National Research Group, the Provincial and Municipal/Survey Spot Center for Disease Control and Prevention, Provincial and Municipal/Survey spots for neurologists and other multiple centers and multiple sectors were established and maintained during the study. As a result, this survey established a nationwide three-level quality control mechanism, based on national, provincial, municipal, and survey sites, which implemented strict quality control for each study site and survey components.

Statistical analysis

The Global Burden of Diseases, Injuries and Risk Factors (GBD) 2010[14] correlation methodology, and SPSS 17.0 Statistical Analysis Software were applied for data processing. All of the indices adjusted to the same standard world population composition as same as the GBD 2010 and had been estimated with 95% uncertainty interval (95%UI). The width of 95%UI provides a mechanism of communicating to users the limitations of estimates for the burden caused by different diseases, injuries and risk factors. Uncertainty around cause-specific YLLs, YLDs and DALYs were calculated incorporating uncertainty in levels of all-cause mortality, cause-specific mortality, prevalence, and disability weights. YLLs were defined as total number of deaths (∑) due to stroke in x-age group multiplied by standard life expectancy in x-age group[15, 16]. In this study, all age groups were divided into 18 age groups: 0–364 days, 1–4 years old, 5–9 years old, 10–14 years old, 15–19 years old, 20–24 years old, 25–29 years old, 30–34 years old, 35–39 years old, 40–44 years old, 45–49 years old, 50–54 years old, 55–59 years old, 60–64 years old, 65–69 years old, 70–74 years old, 75–79 years old, and over 80 years old[17]. "∑" represented the cumulative sum of 18 age groups. The death of stroke in this study was limited to time period between September 1, 2012 to August 31, 2013. YLDs were defined as total (∑) number of suffered from stroke sequela disability status in x-age group × corresponding weight of disability × duration of disability(year)[12, 15] In this study we adopted 220 types of classification standards resulted from 289 disabling diseases-1160 sequelae analyzed by GBD 2010. Disability sequel status of stroke were divided into four categories: mild disability, moderate disability, severe disability and critical disability, respectively corresponding to the modified Rankin Scale (mRS) description[13]. This study was limited to the stroke patients born before August 31, 2013. The duration of disability was defined from the onset of stroke leading to disability to August 31, 2013 (confirmed cases of survival) and the duration from the onset time leading to disability to death time-point (before 31 August 2013) (including those who died from other diseases but suffered from stroke previously). “∑” represented the cumulative sum of four types of sequela related disability. DALYs (disability adjusted life years) were defined as YLLs+ YLDs[12, 15, 16].

Results

NESS-China has completed preliminary screening of 596,536 cases among permanent residents in all age groups at 155 survey sites (from 157 Disease Surveillance Points) in 31 provinces[8, 18], among whom 7,030 cases were diagnosed with disability due to stroke before August 31, 2013, and 758 patients died as a result of stroke during September1, 2012 and August 31, 2013 (Table 1).
Table 1

The provincial detail of the population of disabled and death due to stroke and the absolute value of YLLs, YLDs and DALYs of stroke in all age groups obtained by NESS-China at 155 survey sites in 31 provinces nationwide*.

ProvincesDisabled (n)Death (n)YLLs (95%UI)YLDs (95%UI)DALYs (95%UI)DALYs per 100,000 (95%UI)2013 GDP per capita (U.S. Dollar)[26]
Tianjin20517235(221–258)75(61–98)310(296–333)3846(3674–3929)15761
Xizang3013259(252–268)14(7–23)273(266–282)3418(3246–3501)4234
Hubei29246643(602–693)96(55–146)739(698–789)3199(3027–3282)6869
Liaoning25053684(673–698)33(22–47)717(706–731)3194(3022–3277)9959
Heilongjiang60745720(676–774)110(66–164)830(786–884)3132(2960–3215)6057
Inner Mongolia34032528(518–539)43(33–54)571(561–582)3028(2856–3111)10882
Gansu16331505(498–514)20(13–29)525(518–534)2941(2769–3024)3919
Ningxia6713182(175–191)15(8–24)197(190–206)2515(2343–2598)6331
Jilin35127399(389–410)59(49–70)458(448–469)2433(2261–2516)7619
Shandong41243631(591–679)96(56–144)727(687–775)2413(2241–2496)9072
Qinghai7314201(190–215)37(26–51)238(227–252)2100(1928–2183)5871
Henan80141518(469–576)136(87–194)654(605–712)2099(1927–2182)5516
Hunan18736469(459–480)44(34–55)513(503–524)1933(1761–2016)5913
Zhejiang18734396(386–408)47(37–59)443(433–455)1918(1746–2001)11033
Beijing618103(91–118)36(24–51)139(127–154)1859(1687–1942)14889
Hebei46035459(444–481)78(63–100)537(522–559)1823(1651–1906)6232
Shaanxi33222309(286–337)52(29–80)361(338–389)1809(1637–1892)6884
Guangxi15125380(367–394)69(56–83)449(436–463)1768(1596–1851)4920
Xinjiang12112148(135–162)60(47–74)208(195–222)1744(1572–1827)7460
Fujian9222318(311–327)11(4–20)329(322–338)1743(1471–1726)9310
Yunnan16725355(347–369)43(35–57)398(390–412)1735(1563–1818)4062
Anhui36732336(324–351)66(54–81)402(390–417)1584(1412–1667)5098
Guizhou14823302(295–311)21(14–30)323(316–332)1532(1360–1655)3691
Chongqing799110(108–113)8(6–11)118(116–121)1470(1298–1553)6881
Jiangxi18620248(236–262)32(20–46)280(268–294)1436(1264–1522)5120
Shanxi29119234(221–248)63(50–77)297(284–311)1203(1031–1286)5606
Jiangsu23623241(231–252)52(42–63)293(283–304)1200(1022–1277)12032
Sichuan7722300(293–309)13(6–22)313(306–322)1168(996–1251)5230
Hainan35230(17–44)53(40–67)83(70–97)1060(888–1143)5675
Guangdong13713163(153–174)53(43–64)216(206–227)984(812–1067)9430
Shanghai12517(5–20)30(18–43)37(25–50)453(281–536)14442
National level703075810413 (9955–10977)1563 (1105–2127)11976 (11518–12540)2010(1838–2093)6750

*According to the order from high to low of DALYs per 100,000.

*According to the order from high to low of DALYs per 100,000. During September 1, 2012 and August 31, 2013, the total number of YLLs caused by stroke in all age groups in 31 provinces was 10,413 (95% UI: 9955–10977), the total number of YLDs was 1,563 (95% UI: 1105–2127), and the total number of DALYs was 11,976 (95% UI:11518–12540) (Table 1). From September 1, 2012 to August 31, 2013, YLLs rate per 100,000 people of all age groups per year for stroke nationwide was 1,748 (95% UI: 1576–1831), the YLDs rate was 262 (95% UI: 90–345) and the DALYs was 2,010 (95% UI: 1838–2093). Comparing the seven Chinese regions[19, 20], the region with the highest YLLs rates was Northeast, and the lowest rates were observed in South China; the region with the highest YLDs rates was North China while the lowest YLDs rates were observed in Southwest China; the region with the highest DALYs rates was Northeast while the lowest DALYs rates were in South China (Table 2 and Fig 1). 87% of DALYs were due to YLLs and the remaining 13% were due to YLDs. Generally, YLLs took up a dominant proportion of stroke-caused DALYs in China.
Table 2

YLLs, YLDs and DALYs per 100,000 people (95%UI) in seven regions nationwide, and the respective percentage*.

Regions (provinces)YLLs (%)YLDs (%)DALYs
Northeast China (Heilongjiang, Jilin, Liaoning)262(2490–2745) (90%)298(126–381) (10%)2960(2788–3043)
Northwest China (Ningxia, Xinjiang, Qinghai, Shaanxi, Gansu)1951(1779–2034) (84%)366(194–449) (16%)2317(2145–2400)
Central China (Hubei, Hunan, Henan, Jiangxi)1882 (86%)308 (14%)2190(2018–2273)
North China (Beijing, Tianjin, Hebei, Shanxi, Inner Mongolia)1761(1589–1844) (84%)331(159–414) (16%)2092(1920–2175)
East China (Shandong, Jiangsu, Anhui, Zhejiang, Fujian, Shanghai)1489(1317–1572) (86%)233(61–316) (14%)1722(1550–1805)
Southwest China (Sichuan, Yunnan, Guizhou, Xizang, Chongqing)1537(1365–1620) (93%)113(59–196) (7%)1650(1478–1733)
South China (Guangdong, Guangxi, Hainan)1044(872–1127) (77%)318(146–401) (23%)1362(1190–1445)
National level1748(1576–1831) (87%)262(90–345) (13%)2010(1838–2093)

*According to the order from high to low of DALYs per 100,000.

Fig 1

DALYs per 100,000 people in seven regions of China.

The region with the highest DALYs rates was Northeast while the lowest DALYs rates were in South China.

*According to the order from high to low of DALYs per 100,000.

DALYs per 100,000 people in seven regions of China.

The region with the highest DALYs rates was Northeast while the lowest DALYs rates were in South China. During the study period, the rate of YLLs in rural areas was 1964(95%UI:1792–2047)/100,000, the rate of YLDs was 294(95%UI:122–377)/100,000, and the rate of DALYs was 2,258(95%UI:2086–2341)/100,000; the rate of YLLs urban areas was 1,533(95% UI: 1361–1616)/100,000, the YLDs was 229(95% UI: 57–312)/100,000, and the rate DALYs was 1,762(95% UI: 1590–1845)/100,000. NESS-China has completed preliminary screening of 596,536 cases among permanent residents of all age groups at 155 survey sites in 31 provinces, among whom 3915 males and 3115 females were diagnosed with disability due to stroke before August 31, 2013; and 417 males and 341 females died due to stroke during September 1, 2012 and August 31, 2013. During September 1, 2012 and August 31, 2013, the absolute number of YLLs caused by stroke among all age groups in 31 provinces was 5638 males and 4776 females, the absolute number of YLDs was 868 (95% UI: 583–1210) among males and 694 (95% UI: 405–1033) among females, the absolute number of DALYs was 6506 (95% UI: 6221–6848) among males and 5470 (95% UI: 5181–5809) among females. The DALYs rate per 100,000 people was 2171(95% UI: 1999–2254) in males and 1848(95% UI: 1676–1931) in females. Among the 18 age groups analysed, the highest number of YLLs was observed in people aged over 80 years, especially in females (1267 compared to 835 in males) (Fig 2).
Fig 2

The gender and age stratification on the absolute value of YLLs.

The columns indicate the number of YLLs; the lines show the tendency of YLLs at different age groups.

The gender and age stratification on the absolute value of YLLs.

The columns indicate the number of YLLs; the lines show the tendency of YLLs at different age groups.

Discussion

The present study is based on the data from NESS-China, the first epidemiological survey containing the large-scale samples and multiple centers established in 155 survey sites across 31 provinces specially aimed at studying cerebrovascular disease epidemiology[1, 2, 10, 18]. The survey was carried out primarily by trained investigators and professional neurologists who conducted face-to-face interviews and clinical/neurological examination of the study participants. Such cross-sectional surveys with large-scale samples and multiple centers by strict screening can ensure the reliability of stroke related epidemiological data, and can ensure that all quantitative stroke burden indices estimated on this basis are objective and accurate. This study adopts quality control specification at all survey sites nationwide, in order to ensure all quantitative indices are estimated on the same basis. Our finding suggests that stroke is the main cause of YLLs in China, but not YLDs. This is consistent with the GBD 2010 Study results[12] that showed that YLDs caused by stroke mean ranked 25th (27th in China) among 289 disabling diseases and injures causing 1160 sequelae in all 21 GBD epidemiological regions[15, 21]. However, DALYs caused by stroke ranked 3th in global among the 21 regions and 1st in China (the top three diseases were stroke, ischemic heart disease and lung cancer)[1, 15]. Considering the rising number of people suffering from a stroke and the high related disability rate worldwide, YLDs continues to appear as an important metric for evaluating stroke related nonfatal health impact. It also appears to possess far-reaching significance for reducing disability rate and redeeming years of life lived with disability[22, 23]. The DALYs rates in China appeared to be higher compared to global GBD 2010 DALYs rate, with a significant difference (2,010 VS 1,484 [15, 16], p <0.001, adjusted to the same standard world population composition). Among the 21 GBD epidemiological regions, DALYs caused by stroke played the dominant role in the demographically and epidemiologically advanced regions such as East Asia (includes China) (Stroke Mean Rank 1 in 291 GBD diseases and injuries), High-income Asia Pacific, Southeast Asia, Eastern Europe, Central Europe, Central Asia and Western Europe. Meanwhile, the burden of diseases in the backward regions (science, economy, medical technology, demographic and epidemiological studies are lagging behind) such as sub-Saharan Africa, South Asia and Latin America, the leading volume of DALYs were due to communicable diseases and nutritional deficiencies, however not the cardiovascular and circulatory diseases includes stroke (Table 3). The heterogeneity across 21 regions in the burden of diseases highlighted how important it will be to make estimates at the national levels.
Table 3

DALYs per 100000 caused by stroke and stroke Mean Rank (95%UI) among the 21 GBD epidemiological regions [15] and China*.

Epidemiological Regions or CountriesDALYsStroke Mean Rank**
Eastern Europe3914(3742–3997)2(1–3)
Central Europe3444(3272–3527)2(1–3)
Central Asia2661(2489–2744)3(2–5)
East Asia2192(2020–2275)1(1–2)
Western Europe2045(1873–2128)3(2–5)
High-income North America2035(1863–2118)7(3–11)
North Africa and Middle East2026(1854–2109)4(3–8)
China***2010(1838–2093)1(1–3)
High-income Asia Pacific1878(1706–1961)1(1–2)
Southern Latin America1875(1703–1958)3(2–6)
Australasia1722(1550–1805)5(4–9)
Tropical Latin America1720(1548–1803)4(3–5)
Southeast Asia1718(1546–1801)1(1–2)
Central Latin America1252(1080–1335)11(7–14)
Andean Latin America1098(926–1181)11(7–17)
South Asia1096(924–1179)12(8–15)
Caribbean939(767–1022)3(1–4)
Oceania783(611–866)11(7–14)
Southern sub-Saharan Africa626(454–709)7(6–13)
Central sub-Saharan Africa485(313–568)14(12–16)
Eastern sub-Saharan Africa470(298–553)16(10–20)
Western sub-Saharan Africa313(141–396)16(11–22)
Global1484(1312–1567)3(2–5)

*According to the order from high to low of DALYs per 100,000.

**Ranking in 291 GBD diseases and injuries.

*** The data of our survey from “National Epidemiological Survey of Stroke in China” (NESS-China).

*According to the order from high to low of DALYs per 100,000. **Ranking in 291 GBD diseases and injuries. *** The data of our survey from “National Epidemiological Survey of Stroke in China” (NESS-China). During September 1, 2012 and August 31, 2013, Through the comparison of seven different regions, rural and urban areas in this study[19, 20], the highest value of DALYs caused by stroke was found in the Northeast China and the rural areas while the lowest in South China and the urban areas. With reference to the gender and age stratification with burden of stroke, the value of DALYs in males was higher than in females generally. However, among the 18 age groups analysed, the highest number of YLLs was observed in people aged over 80 years, especially in females. As shown in the Fig 2, YLLs caused by stroke in females was significantly higher than in males for 45–49 years and over 80 years age group, maybe it was due to the perimenopausal period that caused females loss of estrogen to prevent cardio-cerebrovascular diseases. All of the above difference was statistically significant (p<0.001). The geographical, gender and age differences observed in stroke burden in China may be related to inter-regional demographic characteristic differences, regional medical treatment levels, population economy income conditions, etiological stroke subtypes and other risk factors, which means further analysis and assessments are needed[24]. Although morbidity and mortality rates have been declining in most high-income countries for the past two decades, they have been continuously rising in low and middle-income countries including China. This may be due to the life-style transformation, differences in medical conditions, clinical diagnosis and treatment levels, or the deficiency in high risk groups screening and management. The prevalence rate and burden of stroke is growing rapidly worldwide[25]. Currently, stroke related risk factors such as high blood pressure, diabetes mellitus, and hyperlipemia have also been rising[1, 26], and given the smoking rates have not significantly changed in developing countries, the morbidity rate, prevalence rate and death rate are all expected to rise in the near future[27]. China is facing rapid growth of this disease and the burden of stroke requires further investigation and study that would preferably include multiple centers, and large-scale assessments of various factors. Establishing a national stroke register is an urgent issue. Dynamic epidemiology monitoring, clinical diagnosis and treatment of cerebrovascular diseases, screening and management of disease and high-risk population, study and promotion of suitable intervention technologies, are all indispensable for constructing a useful and effective system suitable for coping with cerebrovascular diseases in view of existing national conditions. This would furthermore help strengthen the implementation of primary and secondary prevention strategies, so as to reduce the huge health impact of stroke in China on individual and societal level[28]. This study may serve as a useful guide for control planning strategy, prevention and treatment integration, and dynamic monitoring reinforcement in differently developed regions[1, 29, 30]. The updates would not only provide a mechanism both to assess the latest cross-sectional surveys’ evidences but also to promote accountability of health systems for achieving reductions in the burden of stroke. Furthermore, despite this complexity and diversity, important medical health and public services fundamental challenges are readily identifiable for which technologies and knowledge exist to substantially reduce or eliminate their impact on burden of disease rankings. The sustained commitment of governments, medical workers and the public health community to do so is crucial, on the basis of the essential health intelligence that regular burden of stroke updates can provide promptly.
  24 in total

Review 1.  Realignment of incentives for health-care providers in China.

Authors:  Winnie Chi-Man Yip; William Hsiao; Qingyue Meng; Wen Chen; Xiaoming Sun
Journal:  Lancet       Date:  2010-03-27       Impact factor: 79.321

2.  Regional inequality in health and its determinants: evidence from China.

Authors:  Pengqian Fang; Siping Dong; Jingjing Xiao; Chaojie Liu; Xianwei Feng; Yiping Wang
Journal:  Health Policy       Date:  2009-09-06       Impact factor: 2.980

3.  Healthy life expectancy for 187 countries, 1990-2010: a systematic analysis for the Global Burden Disease Study 2010.

Authors:  Joshua A Salomon; Haidong Wang; Michael K Freeman; Theo Vos; Abraham D Flaxman; Alan D Lopez; Christopher J L Murray
Journal:  Lancet       Date:  2012-12-15       Impact factor: 79.321

Review 4.  Epidemiology and the global burden of stroke.

Authors:  Debraj Mukherjee; Chirag G Patil
Journal:  World Neurosurg       Date:  2011-12       Impact factor: 2.104

5.  Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort.

Authors:  W D Rosamond; A R Folsom; L E Chambless; C H Wang; P G McGovern; G Howard; L S Copper; E Shahar
Journal:  Stroke       Date:  1999-04       Impact factor: 7.914

6.  Prevalence, Incidence, and Mortality of Stroke in China: Results from a Nationwide Population-Based Survey of 480 687 Adults.

Authors:  Wenzhi Wang; Bin Jiang; Haixin Sun; Xiaojuan Ru; Dongling Sun; Linhong Wang; Limin Wang; Yong Jiang; Yichong Li; Yilong Wang; Zhenghong Chen; Shengping Wu; Yazhuo Zhang; David Wang; Yongjun Wang; Valery L Feigin
Journal:  Circulation       Date:  2017-01-04       Impact factor: 29.690

7.  Age-specific and sex-specific mortality in 187 countries, 1970-2010: a systematic analysis for the Global Burden of Disease Study 2010.

Authors:  Haidong Wang; Laura Dwyer-Lindgren; Katherine T Lofgren; Julie Knoll Rajaratnam; Jacob R Marcus; Alison Levin-Rector; Carly E Levitz; Alan D Lopez; Christopher J L Murray
Journal:  Lancet       Date:  2012-12-15       Impact factor: 79.321

8.  Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010.

Authors:  Joshua A Salomon; Theo Vos; Daniel R Hogan; Michael Gagnon; Mohsen Naghavi; Ali Mokdad; Nazma Begum; Razibuzzaman Shah; Muhammad Karyana; Soewarta Kosen; Mario Reyna Farje; Gilberto Moncada; Arup Dutta; Sunil Sazawal; Andrew Dyer; Jason Seiler; Victor Aboyans; Lesley Baker; Amanda Baxter; Emelia J Benjamin; Kavi Bhalla; Aref Bin Abdulhak; Fiona Blyth; Rupert Bourne; Tasanee Braithwaite; Peter Brooks; Traolach S Brugha; Claire Bryan-Hancock; Rachelle Buchbinder; Peter Burney; Bianca Calabria; Honglei Chen; Sumeet S Chugh; Rebecca Cooley; Michael H Criqui; Marita Cross; Kaustubh C Dabhadkar; Nabila Dahodwala; Adrian Davis; Louisa Degenhardt; Cesar Díaz-Torné; E Ray Dorsey; Tim Driscoll; Karen Edmond; Alexis Elbaz; Majid Ezzati; Valery Feigin; Cleusa P Ferri; Abraham D Flaxman; Louise Flood; Marlene Fransen; Kana Fuse; Belinda J Gabbe; Richard F Gillum; Juanita Haagsma; James E Harrison; Rasmus Havmoeller; Roderick J Hay; Abdullah Hel-Baqui; Hans W Hoek; Howard Hoffman; Emily Hogeland; Damian Hoy; Deborah Jarvis; Ganesan Karthikeyan; Lisa Marie Knowlton; Tim Lathlean; Janet L Leasher; Stephen S Lim; Steven E Lipshultz; Alan D Lopez; Rafael Lozano; Ronan Lyons; Reza Malekzadeh; Wagner Marcenes; Lyn March; David J Margolis; Neil McGill; John McGrath; George A Mensah; Ana-Claire Meyer; Catherine Michaud; Andrew Moran; Rintaro Mori; Michele E Murdoch; Luigi Naldi; Charles R Newton; Rosana Norman; Saad B Omer; Richard Osborne; Neil Pearce; Fernando Perez-Ruiz; Norberto Perico; Konrad Pesudovs; David Phillips; Farshad Pourmalek; Martin Prince; Jürgen T Rehm; Guiseppe Remuzzi; Kathryn Richardson; Robin Room; Sukanta Saha; Uchechukwu Sampson; Lidia Sanchez-Riera; Maria Segui-Gomez; Saeid Shahraz; Kenji Shibuya; David Singh; Karen Sliwa; Emma Smith; Isabelle Soerjomataram; Timothy Steiner; Wilma A Stolk; Lars Jacob Stovner; Christopher Sudfeld; Hugh R Taylor; Imad M Tleyjeh; Marieke J van der Werf; Wendy L Watson; David J Weatherall; Robert Weintraub; Marc G Weisskopf; Harvey Whiteford; James D Wilkinson; Anthony D Woolf; Zhi-Jie Zheng; Christopher J L Murray; Jost B Jonas
Journal:  Lancet       Date:  2012-12-15       Impact factor: 79.321

9.  Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.

Authors:  Christopher J L Murray; Theo Vos; Rafael Lozano; Mohsen Naghavi; Abraham D Flaxman; Catherine Michaud; Majid Ezzati; Kenji Shibuya; Joshua A Salomon; Safa Abdalla; Victor Aboyans; Jerry Abraham; Ilana Ackerman; Rakesh Aggarwal; Stephanie Y Ahn; Mohammed K Ali; Miriam Alvarado; H Ross Anderson; Laurie M Anderson; Kathryn G Andrews; Charles Atkinson; Larry M Baddour; Adil N Bahalim; Suzanne Barker-Collo; Lope H Barrero; David H Bartels; Maria-Gloria Basáñez; Amanda Baxter; Michelle L Bell; Emelia J Benjamin; Derrick Bennett; Eduardo Bernabé; Kavi Bhalla; Bishal Bhandari; Boris Bikbov; Aref Bin Abdulhak; Gretchen Birbeck; James A Black; Hannah Blencowe; Jed D Blore; Fiona Blyth; Ian Bolliger; Audrey Bonaventure; Soufiane Boufous; Rupert Bourne; Michel Boussinesq; Tasanee Braithwaite; Carol Brayne; Lisa Bridgett; Simon Brooker; Peter Brooks; Traolach S Brugha; Claire Bryan-Hancock; Chiara Bucello; Rachelle Buchbinder; Geoffrey Buckle; Christine M Budke; Michael Burch; Peter Burney; Roy Burstein; Bianca Calabria; Benjamin Campbell; Charles E Canter; Hélène Carabin; Jonathan Carapetis; Loreto Carmona; Claudia Cella; Fiona Charlson; Honglei Chen; Andrew Tai-Ann Cheng; David Chou; Sumeet S Chugh; Luc E Coffeng; Steven D Colan; Samantha Colquhoun; K Ellicott Colson; John Condon; Myles D Connor; Leslie T Cooper; Matthew Corriere; Monica Cortinovis; Karen Courville de Vaccaro; William Couser; Benjamin C Cowie; Michael H Criqui; Marita Cross; Kaustubh C Dabhadkar; Manu Dahiya; Nabila Dahodwala; James Damsere-Derry; Goodarz Danaei; Adrian Davis; Diego De Leo; Louisa Degenhardt; Robert Dellavalle; Allyne Delossantos; Julie Denenberg; Sarah Derrett; Don C Des Jarlais; Samath D Dharmaratne; Mukesh Dherani; Cesar Diaz-Torne; Helen Dolk; E Ray Dorsey; Tim Driscoll; Herbert Duber; Beth Ebel; Karen Edmond; Alexis Elbaz; Suad Eltahir Ali; Holly Erskine; Patricia J Erwin; Patricia Espindola; Stalin E Ewoigbokhan; Farshad Farzadfar; Valery Feigin; David T Felson; Alize Ferrari; Cleusa P Ferri; Eric M Fèvre; Mariel M Finucane; Seth Flaxman; Louise Flood; Kyle Foreman; Mohammad H Forouzanfar; Francis Gerry R Fowkes; Marlene Fransen; Michael K Freeman; Belinda J Gabbe; Sherine E Gabriel; Emmanuela Gakidou; Hammad A Ganatra; Bianca Garcia; Flavio Gaspari; Richard F Gillum; Gerhard Gmel; Diego Gonzalez-Medina; Richard Gosselin; Rebecca Grainger; Bridget Grant; Justina Groeger; Francis Guillemin; David Gunnell; Ramyani Gupta; Juanita Haagsma; Holly Hagan; Yara A Halasa; Wayne Hall; Diana Haring; Josep Maria Haro; James E Harrison; Rasmus Havmoeller; Roderick J Hay; Hideki Higashi; Catherine Hill; Bruno Hoen; Howard Hoffman; Peter J Hotez; Damian Hoy; John J Huang; Sydney E Ibeanusi; Kathryn H Jacobsen; Spencer L James; Deborah Jarvis; Rashmi Jasrasaria; Sudha Jayaraman; Nicole Johns; Jost B Jonas; Ganesan Karthikeyan; Nicholas Kassebaum; Norito Kawakami; Andre Keren; Jon-Paul Khoo; Charles H King; Lisa Marie Knowlton; Olive Kobusingye; Adofo Koranteng; Rita Krishnamurthi; Francine Laden; Ratilal Lalloo; Laura L Laslett; Tim Lathlean; Janet L Leasher; Yong Yi Lee; James Leigh; Daphna Levinson; Stephen S Lim; Elizabeth Limb; John Kent Lin; Michael Lipnick; Steven E Lipshultz; Wei Liu; Maria Loane; Summer Lockett Ohno; Ronan Lyons; Jacqueline Mabweijano; Michael F MacIntyre; Reza Malekzadeh; Leslie Mallinger; Sivabalan Manivannan; Wagner Marcenes; Lyn March; David J Margolis; Guy B Marks; Robin Marks; Akira Matsumori; Richard Matzopoulos; Bongani M Mayosi; John H McAnulty; Mary M McDermott; Neil McGill; John McGrath; Maria Elena Medina-Mora; Michele Meltzer; George A Mensah; Tony R Merriman; Ana-Claire Meyer; Valeria Miglioli; Matthew Miller; Ted R Miller; Philip B Mitchell; Charles Mock; Ana Olga Mocumbi; Terrie E Moffitt; Ali A Mokdad; Lorenzo Monasta; Marcella Montico; Maziar Moradi-Lakeh; Andrew Moran; Lidia Morawska; Rintaro Mori; Michele E Murdoch; Michael K Mwaniki; Kovin Naidoo; M Nathan Nair; Luigi Naldi; K M Venkat Narayan; Paul K Nelson; Robert G Nelson; Michael C Nevitt; Charles R Newton; Sandra Nolte; Paul Norman; Rosana Norman; Martin O'Donnell; Simon O'Hanlon; Casey Olives; Saad B Omer; Katrina Ortblad; Richard Osborne; Doruk Ozgediz; Andrew Page; Bishnu Pahari; Jeyaraj Durai Pandian; Andrea Panozo Rivero; Scott B Patten; Neil Pearce; Rogelio Perez Padilla; Fernando Perez-Ruiz; Norberto Perico; Konrad Pesudovs; David Phillips; Michael R Phillips; Kelsey Pierce; Sébastien Pion; Guilherme V Polanczyk; Suzanne Polinder; C Arden Pope; Svetlana Popova; Esteban Porrini; Farshad Pourmalek; Martin Prince; Rachel L Pullan; Kapa D Ramaiah; Dharani Ranganathan; Homie Razavi; Mathilda Regan; Jürgen T Rehm; David B Rein; Guiseppe Remuzzi; Kathryn Richardson; Frederick P Rivara; Thomas Roberts; Carolyn Robinson; Felipe Rodriguez De Leòn; Luca Ronfani; Robin Room; Lisa C Rosenfeld; Lesley Rushton; Ralph L Sacco; Sukanta Saha; Uchechukwu Sampson; Lidia Sanchez-Riera; Ella Sanman; David C Schwebel; James Graham Scott; Maria Segui-Gomez; Saeid Shahraz; Donald S Shepard; Hwashin Shin; Rupak Shivakoti; David Singh; Gitanjali M Singh; Jasvinder A Singh; Jessica Singleton; David A Sleet; Karen Sliwa; Emma Smith; Jennifer L Smith; Nicolas J C Stapelberg; Andrew Steer; Timothy Steiner; Wilma A Stolk; Lars Jacob Stovner; Christopher Sudfeld; Sana Syed; Giorgio Tamburlini; Mohammad Tavakkoli; Hugh R Taylor; Jennifer A Taylor; William J Taylor; Bernadette Thomas; W Murray Thomson; George D Thurston; Imad M Tleyjeh; Marcello Tonelli; Jeffrey A Towbin; Thomas Truelsen; Miltiadis K Tsilimbaris; Clotilde Ubeda; Eduardo A Undurraga; Marieke J van der Werf; Jim van Os; Monica S Vavilala; N Venketasubramanian; Mengru Wang; Wenzhi Wang; Kerrianne Watt; David J Weatherall; Martin A Weinstock; Robert Weintraub; Marc G Weisskopf; Myrna M Weissman; Richard A White; Harvey Whiteford; Natasha Wiebe; Steven T Wiersma; James D Wilkinson; Hywel C Williams; Sean R M Williams; Emma Witt; Frederick Wolfe; Anthony D Woolf; Sarah Wulf; Pon-Hsiu Yeh; Anita K M Zaidi; Zhi-Jie Zheng; David Zonies; Alan D Lopez; Mohammad A AlMazroa; Ziad A Memish
Journal:  Lancet       Date:  2012-12-15       Impact factor: 79.321

10.  Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.

Authors:  Theo Vos; Abraham D Flaxman; Mohsen Naghavi; Rafael Lozano; Catherine Michaud; Majid Ezzati; Kenji Shibuya; Joshua A Salomon; Safa Abdalla; Victor Aboyans; Jerry Abraham; Ilana Ackerman; Rakesh Aggarwal; Stephanie Y Ahn; Mohammed K Ali; Miriam Alvarado; H Ross Anderson; Laurie M Anderson; Kathryn G Andrews; Charles Atkinson; Larry M Baddour; Adil N Bahalim; Suzanne Barker-Collo; Lope H Barrero; David H Bartels; Maria-Gloria Basáñez; Amanda Baxter; Michelle L Bell; Emelia J Benjamin; Derrick Bennett; Eduardo Bernabé; Kavi Bhalla; Bishal Bhandari; Boris Bikbov; Aref Bin Abdulhak; Gretchen Birbeck; James A Black; Hannah Blencowe; Jed D Blore; Fiona Blyth; Ian Bolliger; Audrey Bonaventure; Soufiane Boufous; Rupert Bourne; Michel Boussinesq; Tasanee Braithwaite; Carol Brayne; Lisa Bridgett; Simon Brooker; Peter Brooks; Traolach S Brugha; Claire Bryan-Hancock; Chiara Bucello; Rachelle Buchbinder; Geoffrey Buckle; Christine M Budke; Michael Burch; Peter Burney; Roy Burstein; Bianca Calabria; Benjamin Campbell; Charles E Canter; Hélène Carabin; Jonathan Carapetis; Loreto Carmona; Claudia Cella; Fiona Charlson; Honglei Chen; Andrew Tai-Ann Cheng; David Chou; Sumeet S Chugh; Luc E Coffeng; Steven D Colan; Samantha Colquhoun; K Ellicott Colson; John Condon; Myles D Connor; Leslie T Cooper; Matthew Corriere; Monica Cortinovis; Karen Courville de Vaccaro; William Couser; Benjamin C Cowie; Michael H Criqui; Marita Cross; Kaustubh C Dabhadkar; Manu Dahiya; Nabila Dahodwala; James Damsere-Derry; Goodarz Danaei; Adrian Davis; Diego De Leo; Louisa Degenhardt; Robert Dellavalle; Allyne Delossantos; Julie Denenberg; Sarah Derrett; Don C Des Jarlais; Samath D Dharmaratne; Mukesh Dherani; Cesar Diaz-Torne; Helen Dolk; E Ray Dorsey; Tim Driscoll; Herbert Duber; Beth Ebel; Karen Edmond; Alexis Elbaz; Suad Eltahir Ali; Holly Erskine; Patricia J Erwin; Patricia Espindola; Stalin E Ewoigbokhan; Farshad Farzadfar; Valery Feigin; David T Felson; Alize Ferrari; Cleusa P Ferri; Eric M Fèvre; Mariel M Finucane; Seth Flaxman; Louise Flood; Kyle Foreman; Mohammad H Forouzanfar; Francis Gerry R Fowkes; Richard Franklin; Marlene Fransen; Michael K Freeman; Belinda J Gabbe; Sherine E Gabriel; Emmanuela Gakidou; Hammad A Ganatra; Bianca Garcia; Flavio Gaspari; Richard F Gillum; Gerhard Gmel; Richard Gosselin; Rebecca Grainger; Justina Groeger; Francis Guillemin; David Gunnell; Ramyani Gupta; Juanita Haagsma; Holly Hagan; Yara A Halasa; Wayne Hall; Diana Haring; Josep Maria Haro; James E Harrison; Rasmus Havmoeller; Roderick J Hay; Hideki Higashi; Catherine Hill; Bruno Hoen; Howard Hoffman; Peter J Hotez; Damian Hoy; John J Huang; Sydney E Ibeanusi; Kathryn H Jacobsen; Spencer L James; Deborah Jarvis; Rashmi Jasrasaria; Sudha Jayaraman; Nicole Johns; Jost B Jonas; Ganesan Karthikeyan; Nicholas Kassebaum; Norito Kawakami; Andre Keren; Jon-Paul Khoo; Charles H King; Lisa Marie Knowlton; Olive Kobusingye; Adofo Koranteng; Rita Krishnamurthi; Ratilal Lalloo; Laura L Laslett; Tim Lathlean; Janet L Leasher; Yong Yi Lee; James Leigh; Stephen S Lim; Elizabeth Limb; John Kent Lin; Michael Lipnick; Steven E Lipshultz; Wei Liu; Maria Loane; Summer Lockett Ohno; Ronan Lyons; Jixiang Ma; Jacqueline Mabweijano; Michael F MacIntyre; Reza Malekzadeh; Leslie Mallinger; Sivabalan Manivannan; Wagner Marcenes; Lyn March; David J Margolis; Guy B Marks; Robin Marks; Akira Matsumori; Richard Matzopoulos; Bongani M Mayosi; John H McAnulty; Mary M McDermott; Neil McGill; John McGrath; Maria Elena Medina-Mora; Michele Meltzer; George A Mensah; Tony R Merriman; Ana-Claire Meyer; Valeria Miglioli; Matthew Miller; Ted R Miller; Philip B Mitchell; Ana Olga Mocumbi; Terrie E Moffitt; Ali A Mokdad; Lorenzo Monasta; Marcella Montico; Maziar Moradi-Lakeh; Andrew Moran; Lidia Morawska; Rintaro Mori; Michele E Murdoch; Michael K Mwaniki; Kovin Naidoo; M Nathan Nair; Luigi Naldi; K M Venkat Narayan; Paul K Nelson; Robert G Nelson; Michael C Nevitt; Charles R Newton; Sandra Nolte; Paul Norman; Rosana Norman; Martin O'Donnell; Simon O'Hanlon; Casey Olives; Saad B Omer; Katrina Ortblad; Richard Osborne; Doruk Ozgediz; Andrew Page; Bishnu Pahari; Jeyaraj Durai Pandian; Andrea Panozo Rivero; Scott B Patten; Neil Pearce; Rogelio Perez Padilla; Fernando Perez-Ruiz; Norberto Perico; Konrad Pesudovs; David Phillips; Michael R Phillips; Kelsey Pierce; Sébastien Pion; Guilherme V Polanczyk; Suzanne Polinder; C Arden Pope; Svetlana Popova; Esteban Porrini; Farshad Pourmalek; Martin Prince; Rachel L Pullan; Kapa D Ramaiah; Dharani Ranganathan; Homie Razavi; Mathilda Regan; Jürgen T Rehm; David B Rein; Guiseppe Remuzzi; Kathryn Richardson; Frederick P Rivara; Thomas Roberts; Carolyn Robinson; Felipe Rodriguez De Leòn; Luca Ronfani; Robin Room; Lisa C Rosenfeld; Lesley Rushton; Ralph L Sacco; Sukanta Saha; Uchechukwu Sampson; Lidia Sanchez-Riera; Ella Sanman; David C Schwebel; James Graham Scott; Maria Segui-Gomez; Saeid Shahraz; Donald S Shepard; Hwashin Shin; Rupak Shivakoti; David Singh; Gitanjali M Singh; Jasvinder A Singh; Jessica Singleton; David A Sleet; Karen Sliwa; Emma Smith; Jennifer L Smith; Nicolas J C Stapelberg; Andrew Steer; Timothy Steiner; Wilma A Stolk; Lars Jacob Stovner; Christopher Sudfeld; Sana Syed; Giorgio Tamburlini; Mohammad Tavakkoli; Hugh R Taylor; Jennifer A Taylor; William J Taylor; Bernadette Thomas; W Murray Thomson; George D Thurston; Imad M Tleyjeh; Marcello Tonelli; Jeffrey A Towbin; Thomas Truelsen; Miltiadis K Tsilimbaris; Clotilde Ubeda; Eduardo A Undurraga; Marieke J van der Werf; Jim van Os; Monica S Vavilala; N Venketasubramanian; Mengru Wang; Wenzhi Wang; Kerrianne Watt; David J Weatherall; Martin A Weinstock; Robert Weintraub; Marc G Weisskopf; Myrna M Weissman; Richard A White; Harvey Whiteford; Steven T Wiersma; James D Wilkinson; Hywel C Williams; Sean R M Williams; Emma Witt; Frederick Wolfe; Anthony D Woolf; Sarah Wulf; Pon-Hsiu Yeh; Anita K M Zaidi; Zhi-Jie Zheng; David Zonies; Alan D Lopez; Christopher J L Murray; Mohammad A AlMazroa; Ziad A Memish
Journal:  Lancet       Date:  2012-12-15       Impact factor: 79.321

View more
  13 in total

1.  Risk factors and pathogenic microorganism characteristics for pneumonia in convalescent patients with stroke: A retrospective study of 380 patients from a rehabilitation hospital: A retrospective study of risk factors and pathogenic microorganism characteristics for pneumonia in convalescent patients with stroke.

Authors:  Jia Xu; Zhiling Yang
Journal:  J Stroke Cerebrovasc Dis       Date:  2020-05-14       Impact factor: 2.136

2.  Association between PPARG genetic polymorphisms and ischemic stroke risk in a northern Chinese Han population: a case-control study.

Authors:  Yan-Zhe Wang; He-Yu Zhang; Fang Liu; Lei Li; Shu-Min Deng; Zhi-Yi He
Journal:  Neural Regen Res       Date:  2019-11       Impact factor: 5.135

3.  Herbal Compatibility of Ginseng and Rhubarb Exerts Synergistic Neuroprotection in Cerebral Ischemia/Reperfusion Injury of Rats.

Authors:  Wen-Ting Yang; Yong Wang; Yi-Hua Shi; Huan Fu; Zhen Xu; Qing-Qing Xu; Guo-Qing Zheng
Journal:  Front Physiol       Date:  2019-09-13       Impact factor: 4.566

4.  Risk factors and pathogenic microorganism characteristics for pneumonia in convalescent patients with stroke: A retrospective study of 380 patients from a rehabilitation hospital.

Authors:  Jia Xu; Zhiling Yang
Journal:  J Stroke Cerebrovasc Dis       Date:  2020-05-14       Impact factor: 2.136

5.  Geometry of the Carotid Artery and Its Association With Pathologic Changes in a Chinese Population.

Authors:  Yiyao Cui; Xiaoshuo Lv; Feng Wang; Jie Kong; Hao Zhao; Zhidong Ye; Chaozeng Si; Lin Pan; Peng Liu; Jianyan Wen
Journal:  Front Physiol       Date:  2020-01-21       Impact factor: 4.566

6.  The natural course of unruptured intracranial aneurysms in a Chinese cohort: protocol of a multi-center registration study in CIAP.

Authors:  Haixiao Liu; Wei Guo; Sishi Xiang; Peng Hu; Feifei Sun; Junmei Gao; Xiaoyang Zhang; Ping Wang; Wenting Jing; Lei Zhang; Xinjian Yang; Chuanzhi Duan; Min He; Hongqi Zhang; Yan Qu
Journal:  J Transl Med       Date:  2019-10-22       Impact factor: 5.531

7.  Neuromodulatory Effect of Sensorimotor Network Functional Connectivity of Temporal Three-Needle Therapy for Ischemic Stroke Patients with Motor Dysfunction: Study Protocol for a Randomized, Patient-Assessor Blind, Controlled, Neuroimaging Trial.

Authors:  Ning Zhao; Hong Zhang; Tongyan Liu; Jiao Liu; Yun Xiang; Guojian Shu; Chunzhen Li; Jingwen Xie; Lidian Chen
Journal:  Evid Based Complement Alternat Med       Date:  2021-01-04       Impact factor: 2.629

8.  Effect of 'hand and foot acupuncture with twelve needles' on hemiplegia patients with 'qi deficiency and blood stasis' syndrome in the convalescent stage of Ischaemic stroke: study protocol for a randomised controlled trial.

Authors:  Wei-Hao Fang; Gui-Ling Wang; Qiang Liu; Xiao Ding; Zhen-Yao Wang; Xin-Wei Wang; Xiao-Wei Yang; Yang Yang; Da-Wei Zhang; Qing Wei; Hu Zhang
Journal:  Trials       Date:  2021-03-18       Impact factor: 2.279

9.  Superoxide Dismutase Gene Polymorphism is Associated With Ischemic Stroke Risk in the China Dali Region Han Population.

Authors:  Xitong Yang; Sulian Yang; Hongyang Xu; Dan Liu; Yuanyuan Zhang; Guangming Wang
Journal:  Neurologist       Date:  2021-03-04       Impact factor: 1.524

10.  Acupuncture for poststroke hemiplegia focusing on cerebral bilateral connections: study protocol for a randomised controlled neuroimaging trial.

Authors:  Lan Jiang; Hualei Geng; Mengxin Lu; Zhongming Du; Pei Chen; Xiao Han; Yue Wang; Lixin Tang; Zhongjian Tan; Hua Zhang; Yihuai Zou
Journal:  BMJ Open       Date:  2020-04-01       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.